<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TEST" NEWID="19372" OLDID="7208" TOPICS="NO">
<DATE>19-JUN-1987 14:57:41.40</DATE>
<TOPICS/>
<PLACES><D>usa</D><D>canada</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F 
   f2068 reute
d f BC-LIPOSOME-&lt;LIPO.O&gt;-FOR   06-19 0090</UNKNOWN>
<TEXT> 
<TITLE>LIPOSOME &lt;LIPO.O&gt; FORMS CANADIAN SUBSIDIARY</TITLE>
<DATELINE>    PRINCETON, N.J., June 19 - </DATELINE><BODY>Liposome Co Inc at its annual
meeting announced the formation of a Canadian subsidiary,
Canadian Liposome Co Ltd.
    It said the company cements a relationship with University
of British Columbia researcher Pieter Cullis and his scientific
group who are developing anti-cancer products for Liposome.
    The company also said lead bankers completed Liposome's
stock offering of one mln shares on June 11 at 6.875 dlrs a
share. Liposome said it netted 7,388,750 dlrs.
 Reuter
 </BODY></TEXT>
</REUTERS>